Description
EVOLVE104 is an experimental compound currently in early-phase clinical development for advanced solid tumors. Based on available clinical trial data, this agent has been tested in urothelial and squamous cell carcinomas, with potential tumor-agnostic activity that may extend to colorectal cancer treatment. The drug represents a novel therapeutic approach, though its specific application in colorectal cancer remains limited to research settings.
Mechanism of Action
The precise molecular mechanism of action for EVOLVE104 has not been fully disclosed in publicly available clinical trial information. Based on its tumor-agnostic development approach, the compound likely targets a common oncogenic pathway or cellular mechanism shared across multiple cancer types. Further mechanistic details await publication of clinical trial results and regulatory submissions.
Molecular Targets
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
Quick Info
| Brand Name | Not yet branded |
| Category | Other Medications |
 Status | Experimental |
| Administration | IV |
| Clinical Trials | 1 |
Related Medications
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.